Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|
Quarter | Holdings | Value $ | Bought | Sold | Net | Top Holdings | Form Type | Date Filed |
---|---|---|---|---|---|---|---|---|
Q4 2024 | 62 | $1.43B | +$57M | -$205M | -$148M | SRRK, KRYS, NRIX, ZYME, FOLD | 13F-HR | 2/14/2025, 04:21 PM |
Q3 2024 | 63 | $1.7B | +$43.8M | -$155M | -$111M | KRYS, NRIX, FOLD, IMNM, KYMR | 13F-HR | 11/14/2024, 04:15 PM |
Q2 2024 | 63 | $1.65B | +$47M | -$529M | -$482M | KRYS, FOLD, NRIX, STOK, IMNM | 13F-HR | 8/14/2024, 04:16 PM |
Q1 2024 | 77 | $2.72B | +$468M | -$882M | -$414M | KRYS, FOLD, IMNM, SRRK, FATE | 13F-HR | 5/15/2024, 04:50 PM |
Q4 2023 | 70 | $2.8B | +$465M | -$319M | +$145M | IMGN, KRYS, FOLD, SRRK, RYZB | 13F-HR | 2/14/2024, 04:16 PM |
Q3 2023 | 68 | $2.1B | +$137M | -$372M | -$235M | IMGN, KRYS, FOLD, AKRO, AUGX | 13F-HR | 11/14/2023, 04:15 PM |
Q2 2023 | 72 | $2.61B | +$487M | -$443M | +$43.5M | IMGN, KRYS, FOLD, REPL, AKRO | 13F-HR | 8/14/2023, 04:15 PM |
Q1 2023 | 76 | $2.3B | +$383M | -$273M | +$111M | FOLD, KRYS, ISEE, DCPH, AKRO | 13F-HR | 5/15/2023, 04:15 PM |
Q4 2022 | 69 | $2.44B | +$290M | -$327M | -$36.5M | FOLD, KRYS, AKRO, REPL, FATE | 13F-HR | 2/14/2023, 04:18 PM |
Q3 2022 | 70 | $2.58B | +$313M | -$485M | -$171M | FATE, FOLD, KRYS, ARGX, PLRX | 13F-HR | 11/14/2022, 04:03 PM |
Q2 2022 | 71 | $2.62B | +$275M | -$149M | +$125M | FATE, FOLD, SGEN, ARGX, KRYS | 13F-HR | 8/15/2022, 05:22 PM |
Q1 2022 | 70 | $3.19B | +$179M | -$180M | -$1.25M | FATE, FOLD, ARGX, LIVN, KRYS | 13F-HR | 5/16/2022, 04:13 PM |
Q4 2021 | 71 | $4.4B | +$449M | -$735M | -$286M | FATE, FOLD, SNCE, ARGX, LIVN | 13F-HR | 2/14/2022, 05:07 PM |
Q3 2021 | 75 | $5.73B | +$516M | -$714M | -$198M | FATE, ALLK, IGMS, ARGX, ADCT | 13F-HR | 11/15/2021, 04:16 PM |
Q2 2021 | 86 | $6.76B | +$476M | -$812M | -$336M | FATE, IGMS, BEAM, ARGX, FOLD | 13F-HR | 8/16/2021, 05:00 PM |
Q1 2021 | 86 | $7.1B | +$1.13B | -$1.4B | -$261M | FATE, ALLK, IGMS, ARGX, FOLD | 13F-HR | 5/17/2021, 04:05 PM |
Q4 2020 | 87 | $8.25B | +$1.61B | -$739M | +$872M | FATE, FOLD, ALLK, BEAM, IGMS | 13F-HR | 2/16/2021, 04:06 PM |
Q3 2020 | 81 | $5.45B | +$1.15B | -$1.07B | +$83.4M | FATE, FOLD, IMMU, ARGX, IGMS | 13F-HR | 11/16/2020, 04:09 PM |
Q2 2020 | 80 | $5.42B | +$1.48B | -$724M | +$755M | FATE, FOLD, DCPH, ADCT, ARGX | 13F-HR | 8/14/2020, 04:16 PM |
Q1 2020 | 69 | $3.57B | +$674M | -$674M | +$230K | FATE, FOLD, DCPH, BIIB, IGMS | 13F-HR | 5/15/2020, 04:04 PM |
Q4 2019 | 64 | $4.18B | +$1.11B | -$854M | +$260M | DCPH, ALLK, FOLD, FATE, EPZM | 13F-HR | 2/14/2020, 04:10 PM |
Q3 2019 | 74 | $2.99B | +$709M | -$838M | -$129M | ALLK, FOLD, FATE, DCPH, ALDR | 13F-HR | 11/14/2019, 04:11 PM |
Q2 2019 | 80 | $3.53B | +$596M | -$639M | -$43.3M | ARRY, FOLD, FATE, ARGX, QURE | 13F-HR | 8/14/2019, 04:04 PM |
Q1 2019 | 82 | $3.42B | +$662M | -$300M | +$362M | ARRY, FOLD, FATE, ATRA, ARGX | Restatement | 5/17/2019, 08:56 PM |
Q4 2018 | 78 | $2.49B | +$373M | -$590M | -$217M | ARRY, ATRA, FATE, XNCR, WVE | Restatement | 5/16/2019, 03:34 PM |
Q3 2018 | 83 | $3.25B | +$699M | -$490M | +$209M | ARRY, ATRA, FATE, RGNX, XNCR | Restatement | 5/16/2019, 03:34 PM |
Q2 2018 | 81 | $2.94B | +$705M | -$593M | +$112M | ARRY, FOLD, ATRA, IMGN, XNCR | 13F-HR | 8/14/2018, 04:32 PM |
Q1 2018 | 64 | $2.59B | +$592M | -$522M | +$69.6M | ARRY, ATRA, FOLD, IMGN, XNCR | 13F-HR | 5/15/2018, 04:30 PM |
Q4 2017 | 1 | $6.6M | $0 | $0 | LIFE | New Holdings | 3/8/2018, 04:01 PM | |
Q4 2017 | 70 | $2.3B | +$678M | -$391M | +$288M | ARRY, FOLD, PBYI, CLVSQ, WVE | 13F-HR | 2/14/2018, 05:03 PM |
Q3 2017 | 65 | $2.03B | +$628M | -$467M | +$161M | ARRY, FOLD, PBYI, SGEN, CLVSQ | 13F-HR | 11/14/2017, 04:23 PM |
Q2 2017 | 62 | $1.62B | +$374M | -$424M | -$50.1M | ARRY, FOLD, PEN, PBYI, CLVSQ | 13F-HR | 8/14/2017, 05:39 PM |
Q1 2017 | 60 | $1.54B | +$489M | -$303M | +$186M | ARRY, PEN, FOLD, PBYI, CLVSQ | 13F-HR | 5/15/2017, 04:41 PM |
Q4 2016 | 50 | $1.16B | +$246M | -$231M | +$15.5M | ARRY, SGEN, CLVSQ, PEN, FOLD | 13F-HR | 2/14/2017, 04:40 PM |
Q3 2016 | 51 | $1.26B | +$383M | -$415M | -$31.7M | ARRY, SGEN, FOLD, CLVSQ, GWPH | 13F-HR | 11/14/2016, 06:26 PM |
Q2 2016 | 54 | $1.05B | +$260M | -$255M | +$5.19M | ARRY, FOLD, MDVN, SGEN, ATRA | 13F-HR | 8/15/2016, 06:47 PM |
Q1 2016 | 46 | $966M | +$246M | -$342M | -$95.5M | FOLD, MDVN, CLVSQ, PEN, ARRY | 13F-HR | 5/16/2016, 05:22 PM |
Q4 2015 | 56 | $1.3B | +$365M | -$380M | -$15.3M | FOLD, MDVN, PEN, ARRY, ITCI | 13F-HR | 2/16/2016, 04:53 PM |
Q3 2015 | 58 | $1.32B | +$735M | -$521M | +$214M | FOLD, CLVSQ, ARRY, MDVN, INCY | Restatement | 11/17/2015, 03:23 PM |
Q2 2015 | 55 | $1.22B | +$394M | -$366M | +$27.5M | ARRY, FOLD, VRX, CLVSQ, TEVA | 13F-HR | 8/14/2015, 04:27 PM |
Q1 2015 | 54 | $1.11B | +$435M | -$346M | +$88.3M | ARRY, CLVSQ, FOLD, VRX, TEVA | 13F-HR | 5/15/2015, 07:11 PM |
Q4 2014 | 54 | $918M | +$210M | -$257M | -$47.3M | FOLD, ARRY, VRX, CMRX, RAD | 13F-HR | 2/17/2015, 07:28 PM |
Q3 2014 | 52 | $812M | +$314M | -$345M | -$30.9M | VRX, B108PS, CLVSQ, CELG, FOLD | 13F-HR | 11/14/2014, 04:29 PM |
Q2 2014 | 47 | $822M | +$334M | -$328M | +$5.83M | B108PS, MDT, ARRY, UHS, HCA | 13F-HR | 8/14/2014, 06:52 PM |
Q1 2014 | 55 | $838M | +$363M | -$443M | -$80.4M | B108PS, HCA, A, VRX, CLVSQ | Restatement | 8/19/2014, 02:09 PM |
Q4 2013 | 55 | $796M | $0 | $0 | GILD, CLVSQ, ZBH, CELG, AZN | 13F-HR | 2/14/2014, 05:16 PM |